2674. Microbiome and Cumulative Antibiotic Use as Predictors of Stenotrophomonas maltophilia Infection in Patients with Acute Myeloid Leukemia Receiving Remission-Induction Chemoth...

por Aitken, Samuel L, Aitken, Samuel L, Shelburne, Samuel A, Shelburne, Samuel A, Galloway-Peña, Jessica
Publicado 2019

Management of Gram-Positive Bacterial Disease: Staphylococcus aureus, Streptococcal, Pneumococcal and Enterococcal Infections

por Shelburne, Samuel, Musher, Daniel M.
Publicado 2011

2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia

por Borjan, Jovan, Shelburne, Samuel A, Shelburne, Samuel A, Bhatti, Micah M, Aitken, Samuel L, Aitken, Samuel L
Publicado 2019

1831. Machine Learning Approaches to Predicting Resistance in Pseudomonas aeruginosa

por Greenberg, David E, Kim, Jiwoong, Zhan, Xiaowei, Shelburne, Samuel A, Shelburne, Samuel A, Aitken, Samuel L, Aitken, Samuel L
Publicado 2019

855. Evolution of Group B Streptococcal Capsular Type V Invasive Infections in Neonates and Young Infants: A Whole Genome Sequencing Study

por Flores, Anthony R, Sanson, Misu A, Shah, Brittany J, Rench, Marcia, Shelburne, Samuel A, Shelburne, Samuel A, Baker, Carol J
Publicado 2019

Hyperphosphorylation of the Group A Streptococcal Control of Virulence Regulator Increases Promoter Occupancy Specifically at Virulence Factor-Encoding Genes

por Horstmann, Nicola, Tran, Chau Nguyen, Flores, Anthony R., Shelburne, Samuel A.
Publicado 2023

The in vitro activity of delafloxacin and comparator agents against bacterial pathogens isolated from patients with cancer

por Gerges, Bahgat, Rolston, Kenneth, Shelburne, Samuel A, Rosenblatt, Joel, Prince, Randall, Raad, Issam
Publicado 2023

Structural mechanism of Staphylococcus aureus Hfq binding to an RNA A-tract

por Horstmann, Nicola, Orans, Jillian, Valentin-Hansen, Poul, Shelburne, Samuel A., Brennan, Richard G.
Publicado 2012

In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer

por Rolston, Kenneth, Gerges, Bahgat, Nesher, Lior, Shelburne, Samuel A, Prince, Randall, Raad, Issam
Publicado 2023

605. Identification of a Novel CMY-Variant Enzyme in a Clinical Escherichia coli Strain with Treatment-Emergent Ceftazidime–Avibactam Resistance

por Aitken, Samuel L, Aitken, Samuel L, Endres, Bradley T, Khan, Ayesha, Shropshire, William C, Borjan, Jovan, Bhatti, Micah M, Sahasrabhojane, Pranoti V, Doi, Yohei, Shields, Ryan K, Shelburne, Samuel A, Shelburne, Samuel A
Publicado 2019

735. Contribution of the Oral Cavity and Gastrointestinal Microbiome on Bloodstream Infections inLeukemia Patients

por McMahon, Stephanie, Microbiology, B S, Galloway-Peña, Jessica, Sahasrabhojane, Pranoti V, Shelburne, Samuel A
Publicado 2022

2682. Prophylaxis-Driven Molecular Epidemiology of Pseudomonas aeruginosa Bloodstream Infections in Adults With Leukemia

por Endres, Bradley T, Buege, Michael J, Marx, Kayleigh, Sahasrabhojane, Pranoti V, Galloway-Peña, Jessica, Garey, Kevin W, Kim, Jiwoong, Greenberg, David E, Zhan, Xiaowei, Shelburne, Samuel A, Shelburne, Samuel A, Aitken, Samuel L, Aitken, Samuel L
Publicado 2019

2248. Clinical and Microbiological Outcomes Associated with Real-World Use of Ceftolozane/Tazobactam

por Cabrera, Nicolo, Tran, Truc T, Miller, William R, Dinh, An Q, Hanson, Blake, Munita, Jose M, Shelburne, Samuel A, Shelburne, Samuel A, Aitken, Samuel L, Aitken, Samuel L, Garey, Kevin W, Puzniak, Laura A, Arias, Cesar A
Publicado 2019

Identification and Whole Genome Sequencing of the First Case of Kosakonia radicincitans Causing a Human Bloodstream Infection

por Bhatti, Micah D., Kalia, Awdhesh, Sahasrabhojane, Pranoti, Kim, Jiwoong, Greenberg, David E., Shelburne, Samuel A.
Publicado 2017

Erratum to: An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data

por Wadsworth, W. Duncan, Argiento, Raffaele, Guindani, Michele, Galloway-Pena, Jessica, Shelburne, Samuel A., Vannucci, Marina
Publicado 2017

305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy

por Spitznogle, Sarah L, Rausch, Caitlin R, Bhatti, Micah M, Shelburne, Samuel A, Aitken, Samuel L
Publicado 2020

1521. Non-faecium Non-faecalis enterococcal bloodstream infections in patients with cancer

por Axell-House, Dierdre B, Egge, Stephanie L, Tran, Cecilia, Shelburne, Samuel A, Arias, Cesar A
Publicado 2022

Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

por Rolston, Kenneth V. I., Gerges, Baghat, Shelburne, Samuel, Aitken, Samuel L., Raad, Issam, Prince, Randall A.
Publicado 2020

664. LiaX as a Surrogate Marker of Daptomycin Susceptibility in Multidrug-Resistant Enterococcus faecium Recovered from Cancer Patients

por Axell-House, Dierdre B, Khan, Ayesha, Shamoo, Yousif, Shelburne, Samuel A, Tran, Truc T, Arias, Cesar A
Publicado 2020

60. Creation and Comparison of a Machine Learning Decision Tree and Traditional Risk Score to Predict Ceftriaxone Resistance in Cancer Patients with E. coli Bacteremia

por Moc, Courtney, Shropshire, William, McDaneld, Patrick, Shelburne, Samuel A, Aitken, Samuel L, Aitken, Samuel L
Publicado 2021